Relapse Prevention for Bipolar Type-II Disorder

Completed · Phase 4

Conditions studied: Bipolar Disorder, Depression

In brief

This 62-week study will compare the safety and effectiveness of fluoxetine (Prozac®), lithium, the combination of these two medications, and placebo in treating and preventing recurrent depressive episodes in people with bipolar type II disorder.

Key facts

Study ID

NCT00044616

Run by

University of Pennsylvania

People needed

180

Starts

2001-02-01

Expected to finish

2007-01-01

Last updated by the study team

2015-10-06

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Bipolar II Depression

Where it is running

• Depression Research Unit, Univ Penn — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.